Ionization, lipophilicity and solubility properties of repaglinideMANDIC, Zoran; GABELICA, Vesna.Journal of pharmaceutical and biomedical analysis. 2006, Vol 41, Num 3, pp 866-871, issn 0731-7085, 6 p.Article

Effects of the SLCO1B1*1B haplotype on the pharmacokinetics and pharmacodynamics of repaglinide and nateglinideKALLIOKOSKI, Annikka; BACKMAN, Janne T; NEUVONEN, Pertti J et al.Pharmacogenetics and genomics (Print). 2008, Vol 18, Num 11, pp 937-942, issn 1744-6872, 6 p.Article

A Comparative Study of First-Derivative Spectrophotometry and Column High-Performance Liquid Chromatography Applied to the Determination of Repaglinide in Tablets and for Dissolution TestingALKHALIDI, Bashar A; SHTAIWI, Majed; ALKHATIB, Hatim S et al.Journal of AOAC International. 2008, Vol 91, Num 3, pp 530-535, issn 1060-3271, 6 p.Article

Population pharmacokinetic modelling of repaglinide in healthy volunteers by using Non-Parametric Adaptive Grid AlgorithmRUZILAWATI, A. B; MOHD SUHAIMI, A. W; GAN, S. H et al.Journal of clinical pharmacy and therapeutics (Print). 2010, Vol 35, Num 1, pp 105-112, issn 0269-4727, 8 p.Article

Repaglinide/bedtime NPH insulin is comparable to twice-daily NPH insulinPANELO, Araceli; WING, Jeffrey Robert.Diabetes care. 2005, Vol 28, Num 7, pp 1789-1790, issn 0149-5992, 2 p.Article

Alternative efficient tritium labeling of repaglinideVLIEGEN, Maarten; HASPESLAGH, Pieter; VERLUYTEN, Willy et al.Journal of labelled compounds & radiopharmaceuticals. 2012, Vol 55, Num 3-4, pp 155-157, issn 0362-4803, 3 p.Article

Development and validation of a new high-performance liquid chromatography method for the determination of gliclazide and repaglinide in pharmaceutical formulationsBERECKA, Anna; GUMIENICZEK, Anna; HOPKALA, Hanna et al.Journal of AOAC International. 2006, Vol 89, Num 2, pp 319-325, issn 1060-3271, 7 p.Article

In vitro characterization and in vivo toxicity study of repaglinide loaded poly (methyl methacrylate) nanoparticlesDHANA LEKSHMI, U. M; POOVI, G; KISHORE, Narra et al.International journal of pharmaceutics (Print). 2010, Vol 396, Num 1-2, pp 194-203, issn 0378-5173, 10 p.Article

Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics and pharmacodynamics of repaglinide: potentially hazardous interaction between gemfibrozil and repaglinideNIEMI, M; BACKMAN, J. T; NEUVONEN, M et al.Diabetologia (Berlin). 2003, Vol 46, Num 3, pp 347-351, issn 0012-186X, 5 p.Article

Achieving Glycosylated Hemoglobin Targets Using the Combination of Repaglinide and Metformin in Type 2 Diabetes : A Reanalysis of Earlier Data in Terms of Current TargetsMOSES, Robert G.Clinical therapeutics. 2008, Vol 30, Num 3, pp 552-554, issn 0149-2918, 3 p.Article

Method development and validation of repaglinide in human plasma by HPLC and its application in pharmacokinetic studiesABU BAKAR RUZILAWATI; MOHD SUHAIMI ABD. WAHAB; IMRAN, Ahmad et al.Journal of pharmaceutical and biomedical analysis. 2007, Vol 43, Num 5, pp 1831-1835, issn 0731-7085, 5 p.Article

Lack of effect of bezafibrate and fenofibrate on the pharmacokinetics and pharmacodynamics of repaglinideKAJOSAARI, Lauri I; BACKMAN, Janne T; NEUVONEN, Mikko et al.British journal of clinical pharmacology. 2004, Vol 58, Num 4, pp 390-396, issn 0306-5251, 7 p.Article

Transfer of repaglinide in the dually perfused human placenta and the role of organic anion transporting polypeptides (OATPs)TERTTI, Kristiina; PETSALO, Aleksanteri; NIEMI, Mikko et al.European journal of pharmaceutical sciences. 2011, Vol 44, Num 3, pp 181-186, issn 0928-0987, 6 p.Article

Severe Hypoglycemia from Clarithromycin-Repaglinide Drug InteractionKHAMAISI, Mogher; LEITERSDORF, Eran.Pharmacotherapy. 2008, Vol 28, Num 5, pp 682-684, issn 0277-0008, 3 p.Article

A novel calcium silicate based microspheres of repaglinide : In vivo investigationsJAIN, Sunil K; AGRAWAL, Govind P; JAIN, Narendra K et al.Journal of controlled release. 2006, Vol 113, Num 2, pp 111-116, issn 0168-3659, 6 p.Article

The impact of CYP2C8 polymorphism and grapefruit juice on the pharmacokinetics of repaglinideBIDSTRUP, Tanja Busk; DAMKIER, Per; OLSEN, Anette Kristensen et al.British journal of clinical pharmacology. 2006, Vol 61, Num 1, pp 49-57, issn 0306-5251, 9 p.Article

Repaglinide versus nateglinide monotherapy: A randomized, multicenter studyROSENSTOCK, Julio; HASSMAN, David R; MADDER, Robert D et al.Diabetes care. 2004, Vol 27, Num 6, pp 1265-1270, issn 0149-5992, 6 p.Article

Review of prandial glucose regulation with repaglinide: a solution to the problem of hypoglycaemia in the treatment of Type 2 diabetes?NATTRASS, M; LAURITZEN, T.International journal of obesity. Supplement. 2000, Vol 24, Num 3, pp S21-S31, issn 1359-6373Conference Paper

Sécrétion d'insuline et répaglinide = Insulin secretion and repaglinideOWENS, D.Diabetes & metabolism. 1999, Vol 25, pp 17-19, issn 1262-3636, SUP7Conference Paper

Porous carrier based floating granular delivery system of repaglinideJAIN, Sunil K; AGRAWAL, Govind P; JAIN, Narendra K et al.Drug development and industrial pharmacy. 2007, Vol 33, Num 4, pp 381-391, issn 0363-9045, 11 p.Article

CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinideBIDSTRUP, Tanja Busk; BJØRNSDOTTIR, Inga; SIDELMANN, Ulla Grove et al.British journal of clinical pharmacology. 2003, Vol 56, Num 3, pp 305-314, issn 0306-5251, 10 p.Article

Drug-drug and food-drug pharmacokinetic interactions with new insulinotropic agents repaglinide and nateglinideSCHEEN, André J.Clinical pharmacokinetics. 2007, Vol 46, Num 2, pp 93-108, issn 0312-5963, 16 p.Article

Cyclosporine markedly raises the plasma concentrations of repaglinideKAJOSAARI, Lauri I; NIEMI, Mikko; NEUVONEN, Mikko et al.Clinical pharmacology and therapeutics. 2005, Vol 78, Num 4, pp 388-399, issn 0009-9236, 12 p.Article

A double-site absorption model fits to pharmacokinetic data of repaglinide in manLIU, X. D; JI, H. F; XIE, L et al.European journal of drug metabolism and pharmacokinetics. 2000, Vol 25, Num 2, pp 115-119, issn 0378-7966Article

Effect of the CYP2C8 Genotype on the Pharmacokinetics and Pharmacodynamics of RepaglinideTOMALIK-SCHARTE, Dorota; FUHR, Uwe; HELLMICH, Martin et al.Drug metabolism and disposition. 2011, Vol 39, Num 5, pp 927-932, issn 0090-9556, 6 p.Article